These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26071879)

  • 1. More than a scaffold: Stromal modulation of tumor immunity.
    Johansson A; Hamzah J; Ganss R
    Biochim Biophys Acta; 2016 Jan; 1865(1):3-13. PubMed ID: 26071879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.
    Johansson-Percival A; He B; Li ZJ; Kjellén A; Russell K; Li J; Larma I; Ganss R
    Nat Immunol; 2017 Nov; 18(11):1207-1217. PubMed ID: 28892469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Strategical consideration of the interaction between tumor microenvironment and tumor immunity].
    Fujiwara H
    Rinsho Ketsueki; 2018; 59(10):1895-1904. PubMed ID: 30305490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.
    Philips GK; Atkins M
    Int Immunol; 2015 Jan; 27(1):39-46. PubMed ID: 25323844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
    Puré E; Lo A
    Cancer Immunol Res; 2016 Apr; 4(4):269-78. PubMed ID: 27036971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.
    Chouaib S; Noman MZ; Kosmatopoulos K; Curran MA
    Oncogene; 2017 Jan; 36(4):439-445. PubMed ID: 27345407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine.
    Kwilas AR; Ardiani A; Donahue RN; Aftab DT; Hodge JW
    J Transl Med; 2014 Nov; 12():294. PubMed ID: 25388653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune suppressive mechanisms in the tumor microenvironment.
    Munn DH; Bronte V
    Curr Opin Immunol; 2016 Apr; 39():1-6. PubMed ID: 26609943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment.
    Menon H; Ramapriyan R; Cushman TR; Verma V; Kim HH; Schoenhals JE; Atalar C; Selek U; Chun SG; Chang JY; Barsoumian HB; Nguyen QN; Altan M; Cortez MA; Hahn SM; Welsh JW
    Front Immunol; 2019; 10():193. PubMed ID: 30828330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsic modulation of lymphocyte function by stromal cell network: advance in therapeutic targeting of cancer.
    Görgün G; Anderson KC
    Immunotherapy; 2011 Oct; 3(10):1253-64. PubMed ID: 21995575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local targets for immune therapy to cancer: tumor draining lymph nodes and tumor microenvironment.
    Fransen MF; Arens R; Melief CJ
    Int J Cancer; 2013 May; 132(9):1971-6. PubMed ID: 22858832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the tumor microenvironment on the efficacy of tumor immunotherapy.
    Neeson P; Paterson Y
    Immunol Invest; 2006; 35(3-4):359-94. PubMed ID: 16916758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapy.
    Fassnacht M; Lee J; Milazzo C; Boczkowski D; Su Z; Nair S; Gilboa E
    Clin Cancer Res; 2005 Aug; 11(15):5566-71. PubMed ID: 16061874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the stroma by T cells to limit tumor growth.
    Zhang B
    Cancer Res; 2008 Dec; 68(23):9570-3. PubMed ID: 19047130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation and immunity in the tumor environment.
    Maletzki C; Emmrich J
    Dig Dis; 2010; 28(4-5):574-8. PubMed ID: 21088404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Tumor Microenvironment: The Protumor Effects of IL-17 Related to Cancer Type.
    Fabre J; Giustiniani J; Garbar C; Antonicelli F; Merrouche Y; Bensussan A; Bagot M; Al-Dacak R
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Priming of the Tumor Microenvironment by Radiation.
    Jiang W; Chan CK; Weissman IL; Kim BYS; Hahn SM
    Trends Cancer; 2016 Nov; 2(11):638-645. PubMed ID: 28741502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy.
    Tartour E; Pere H; Maillere B; Terme M; Merillon N; Taieb J; Sandoval F; Quintin-Colonna F; Lacerda K; Karadimou A; Badoual C; Tedgui A; Fridman WH; Oudard S
    Cancer Metastasis Rev; 2011 Mar; 30(1):83-95. PubMed ID: 21249423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.